Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
Holding JSPR?
Track your performance easily

Jasper Therapeutics (JSPR) Ownership - Who Owns Jasper Therapeutics?

581 Followers

Jasper Therapeutics (JSPR) Ownership Overview

27.43%8.79%13.91%7.94%41.93%
27.43% Insiders
13.91% Other Institutional Investors
7.94% ETFs
41.93% Public Companies and Individual Investors
The ownership structure of Jasper Therapeutics (JSPR) stock is a mix of institutional, retail, and individual investors. Approximately 30.64% of the company’s stock is owned by Institutional Investors, 27.43% is owned by Insiders, and 41.93% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 12, 2024
xxxxxxxxxxxxx
$2460500
Feb 09, 2024
xxxxxxxxxxxxx
$4532500
Nov 30, 2023
xxxxxxxxxxxxx
$6400
Nov 22, 2023
xxxxxxxxxxxxx
$6300

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$9396438

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,433,828Insider9.49%35,171,801
1,159,012Insider7.67%28,430,564
1,066,189Insider7.06%26,153,616
669,137Institution4.43%16,413,931
598,842Institution3.96%14,689,594
440,656Institution2.92%10,809,292
413,940Institution2.74%10,153,948
331,188Insider2.19%8,124,042
236,841Institution1.57%5,809,710
120,574Institution0.80%2,957,680

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
598,842Institution3.96%14,689,594
236,841Institution1.57%5,809,710
120,574Institution0.80%2,957,680
117,564Institution0.78%2,883,845
84,250Institution0.56%2,066,653
57,094Institution0.38%1,400,516
32,407Institution0.21%794,944
20,000Institution0.13%490,600
15,363Institution0.10%376,854
10,717Institution0.07%262,888

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
313,667Institution2.08%7,694,252
401,219Institution2.66%7,546,929
188,656Institution1.25%3,548,619
101,285Institution0.67%2,484,521
52,007Institution0.34%978,252
25,704Institution0.17%630,519
21,642Institution0.14%491,057
17,685Institution0.12%401,273
12,560Institution0.08%297,672
11,219Institution0.07%254,559

FAQ

Who Owns Jasper Therapeutics (JSPR)?
According to the latest TipRanks data, approximately 13.91% of the company's stock is held by institutional investors, 27.43% is held by insiders, and 41.93% is held by retail investors.
    What percentage of Jasper Therapeutics (JSPR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 13.91% of Jasper Therapeutics (JSPR) stock is held by institutional investors.
      What percentage of Jasper Therapeutics (JSPR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 41.93% of Jasper Therapeutics (JSPR) stock is held by retail investors.
        Who owns the most shares of Jasper Therapeutics (JSPR)?
        Velan Capital Investment Management LP owns the most shares of Jasper Therapeutics (JSPR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis